Oncogene - Table of Contents alert Volume 36 Issue 7

If you are unable to see the message below, click here to view.

Advertisement 4 million CpGs can't all be wrong. In fact, we all agree that Diagenode's new Premium RRBS solution is perfect for DNA methylation studies. Get better accuracy with low bias - unique sample pooling means fewer bisulfite conversions and amplifications. Multiplex 6 samples per lane for lower costs. Get superior coverage -4 million CpGs. Kits or services: complete kit or service with bioinformatics analysis available. Learn more and watch our webinar on how the protocol works. TABLE OF CONTENTS Volume 36, Issue 7 (February 2017) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Extracellular vesicles swarm the cancer microenvironment: from tumor–stroma communication to drug intervention F Wendler, R Favicchio, T Simon, C Alifrangis, J Stebbing and G Giamas Oncogene 2017 36: 877-884; advance online publication, August 22, 2016; 10.1038/onc.2016.253 Abstract | Full Text Original Articles Top Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression OPEN D Wang, W Shi, Y Tang, Y Liu, K He, Y Hu, J Li, Y Yang and J Song Oncogene 2017 36: 885-898; advance online publication, October 3, 2016; 10.1038/onc.2016.257 Abstract | Full Text PIPKIγ and talin couple phosphoinositide and adhesion signaling to control the epithelial to mesenchymal transition N Thapa, X Tan, S Choi, T Wise and R A Anderson Oncogene 2017 36: 899-911; advance online publication, July 25, 2016; 10.1038/onc.2016.267 Abstract | Full Text Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4 OPEN U Harjes, E Bridges, K M Gharpure, I Roxanis, H Sheldon, F Miranda, L S Mangala, S Pradeep, G Lopez-Berestein, A Ahmed, B Fielding, A K Sood and A L Harris Oncogene 2017 36: 912-921; advance online publication, August 29, 2016; 10.1038/onc.2016.256 Abstract | Full Text Human EHMT2/G9a activates p53 through methylation-independent mechanism M Rada, E Vasileva, L Lezina, D Marouco, A V Antonov, S Macip, G Melino and N A Barlev Oncogene 2017 36: 922-932; advance online publication, July 25, 2016; 10.1038/onc.2016.258 Abstract | Full Text CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells OPEN M Sauer, M Schuldner, N Hoffmann, A Cetintas, K S Reiners, O Shatnyeva, M Hallek, H P Hansen, S Gasser and E P von Strandmann Oncogene 2017 36: 933-941; advance online publication, August 1, 2016; 10.1038/onc.2016.259 Abstract | Full Text The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition OPEN C Battistelli, C Cicchini, L Santangelo, A Tramontano, L Grassi, F J Gonzalez, V de Nonno, G Grassi, L Amicone and M Tripodi Oncogene 2017 36: 942-955; advance online publication, July 25, 2016; 10.1038/onc.2016.260 Abstract | Full Text FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53 OPEN R Molinuevo, A Freije, I de Pedro, S W Stoll, J T Elder and A Gandarillas Oncogene 2017 36: 956-965; advance online publication, July 25, 2016; 10.1038/onc.2016.262 Abstract | Full Text Plk1-mediated stabilization of 53BP1 through USP7 regulates centrosome positioning to maintain bipolarity H Yim, S-B Shin, S U Woo, P C-W Lee and R L Erikson Oncogene 2017 36: 966-978; advance online publication, August 1, 2016; 10.1038/onc.2016.263 Abstract | Full Text mTOR promotes pituitary tumor development through activation of PTTG1 R Chen, J Duan, L Li, Q Ma, Q Sun, J Ma, C Li, X Zhou, H Chen, Y Jing, S Zhao, X Wu and H Zhang Oncogene 2017 36: 979-988; advance online publication, August 15, 2016; 10.1038/onc.2016.264 Abstract | Full Text The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis G Li, M Li, J Hu, R Lei, H Xiong, H Ji, H Yin, Q Wei and G Hu Oncogene 2017 36: 989-998; advance online publication, September 19, 2016; 10.1038/onc.2016.265 Abstract | Full Text RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3 J-W Jang, M-K Kim, Y-S Lee, J-W Lee, D-M Kim, S-H Song, J-Y Lee, B-Y Choi, B Min, X-Z Chi and S-C Bae Oncogene 2017 36: 999-1011; advance online publication, July 18, 2016; 10.1038/onc.2016.266 Abstract | Full Text FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition J M Jeffery, M Kalimutho, P Johansson, D G Cardenas, R Kumar and K K Khanna Oncogene 2017 36: 1012-1022; advance online publication, August 29, 2016; 10.1038/onc.2016.268 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.